Literature DB >> 28840407

Clinical characteristics and risk factors for retinal diabetic neurodegeneration in type 2 diabetes.

Kiyoung Kim1, Eung Suk Kim1, Sang Youl Rhee2, Suk Chon2, Jeong-Taek Woo2, Seung-Young Yu3.   

Abstract

AIMS: To identify clinical characteristics and risk factors of retinal neurodegeneration represented by macular ganglion cell/inner plexiform layer (mGCIPL) thinning in patients with long-standing type 2 diabetes mellitus (T2DM).
METHODS: Patients who had T2DM for >15 years were prospectively recruited from September 2014 to July 2015. Clinical data and samples were collected according to the Common Data Element and Standards of Procedure developed by the Korean Diabetes Association research council. Baseline characteristics included age, gender, family history, medical record of comorbidity, and microvascular complications. All patients underwent optical coherence tomography with automatic segmentation of the mGCIPL in six parafoveal regions. Multivariable regression analysis identified factors associated with mGCIPL thinning.
RESULTS: Of 220 registered patients, 162 were included after ophthalmologic examination. The mean (SD) age was 65.0 (9.3) years, the mean duration of T2DM was 20.5 (4.0) years; mGCIPL thickness was 76.2 (8.5) µm. Hypertension, diabetic retinopathy, statin medication, estimated glomerular filtration rate, conduction velocity of the posterior tibial, peroneal, and sural nerves, and cardiac autonomic neuropathy (CAN) score were significantly correlated with mGCIPL thickness. Multivariate regression analysis showed that the CAN score (coefficient = -1.78, p = 0.001) and sural nerve velocity (coefficient = 0.458, p = 0.035) yielded a significant high regression correlation with mGCIPL thickness (overall R 2 = 0.46).
CONCLUSIONS: This study demonstrated that various clinical features were associated with retinal neurodegeneration in T2DM. In particular, peripheral nerve conduction and autonomic nerve function were confirmed to be strong risk factors for mGCIPL thinning in patients with T2DM.

Entities:  

Keywords:  Diabetic retinal neurodegeneration; Diabetic retinopathy; Macular ganglion cell/inner plexiform layer

Mesh:

Year:  2017        PMID: 28840407     DOI: 10.1007/s00592-017-1043-5

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  4 in total

1.  Plasma amino acids and oxylipins as potential multi-biomarkers for predicting diabetic macular edema.

Authors:  Sang Youl Rhee; Eun Sung Jung; Dong Ho Suh; Su Jin Jeong; Kiyoung Kim; Suk Chon; Seung-Young Yu; Jeong-Taek Woo; Choong Hwan Lee
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

2.  Factors Associated with the Macular Ganglion Cell-Inner Plexiform Layer Thickness in a Cohort of Middle-aged U.S. Adults.

Authors:  Adam J Paulsen; Alex Pinto; Natascha Merten; Yanjun Chen; Mary E Fischer; Guan-Hua Huang; Barbara E K Klein; Carla R Schubert; Karen J Cruickshanks
Journal:  Optom Vis Sci       Date:  2021-03-01       Impact factor: 2.106

3.  The Relationship between Peripheral Nerve Conduction Velocity and Ophthalmological Findings in Type 2 Diabetes Patients with Early Diabetic Retinopathy.

Authors:  Azusa Ito; Hiroshi Kunikata; Masayuki Yasuda; Shojiro Sawada; Keiichi Kondo; Chihiro Satake; Kazuki Hashimoto; Naoko Aizawa; Hideki Katagiri; Toru Nakazawa
Journal:  J Ophthalmol       Date:  2018-02-20       Impact factor: 1.909

4.  Association analysis of SOCS3, JAK2 and STAT3 gene polymorphisms and genetic susceptibility to type 2 diabetes mellitus in Chinese population.

Authors:  Yang Zhang; Chunwen Lin; Rong Chen; Ling Luo; Jialu Huang; Hao Liu; Weiying Chen; Jian Xu; Haibing Yu; Yuanlin Ding
Journal:  Diabetol Metab Syndr       Date:  2022-01-06       Impact factor: 3.320

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.